| Roche Pharma (Schweiz) AG - Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 66152 | | 01 | | Tecentriq 1200 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FF05 | | | | 23.05.2017 | | |
|
| Composition |
| atezolizumabum 1200 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 20 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Atezolizumabum | 1200mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Atezolizumabum | 1200 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Histidine | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3866.57 | 4221.55 | A | SL | No |
|
